CX 2021 Programme
-
-
Live stream 1
- Live stream 2
- CX on demand
- Abstracts on demand
- Satellite Symposia
-
If you have any questions concerning the scientific programme, please contact us at cxsymposium@bibamedical.com
All times are London time BST (British Summer Time), which is GMT+1. The organisers reserve the right to alter timings if necessary.
The Hurting Leg - Thursday, 22nd April
Venue: Livestream 1
Time: 14:00 - 19:30 London time (BST)
The hurting leg and COVID
Time: 14:00 - 14:30 London time (BST)
| Moderators: | Keith Harding, Cardiff, United Kingdom |
| Michael Edmonds, London, United Kingdom |
14:00 - 14:05
The effect of COVID-19 on amputation rates across a 29 hospital system
| Speaker: | Alisha Oropallo, New York, United States |
14:05 - 14:10
Audience participation and discussion
14:10 - 14:15
Opportunity from crisis: Reducing time to treatment for patients with critical limb ischaemia during the coronavirus pandemic
| Speaker: | James Morris, Preston, United Kingdom |
14:15 - 14:20
Audience participation and discussion
14:20 - 14:25
Clinical evaluation of CLTI patients and other frail patients in the era of COVID-19
| Speaker: | Misti Malone, FDA, Silver Spring, United States |
14:25 - 14:30
Audience participation and discussion
The referred acute hurting leg controversies
Time: 14:30 - 15:00 London time (BST)
| Moderators: | Andrew Holden, Auckland, New Zealand |
| Thomas Zeller, Bad Krozingen, Germany |
Roundtable with CLI Global Society: Rapid pathways to diagnosis and treatment to save life and limb
Time: 14:30 - 15:00 London time (BST)
14:30 - 14:35
Obstacles to rapid diagnosis of superficial and deep venous thrombosis with risk of pulmonary embolism and death
| Speaker: | Barry Katzen, Miami, United States |
14:35 - 14:40
Obstacles to rapid treatment of Chronic Limb-Threatening Ischaemia
| Speaker: | Michael Jaff, Boston, United States |
14:40 - 14:45
Why threat to life and limb from the hurting leg remains
| Speaker: | Jos van den Berg, Lugano, Switzerland |
14:45 - 15:00
Audience participation and discussion
Networking break
Time: 15:00 - 15:30 London time (BST)
Satellite Symposium: Advanced image-guided therapy to improve procedure outcomes in CLI patients?
Time: 15:00 - 15:30 London time (BST)
| Moderator: | Patrick F.S. Chong, Frimley, United Kingdom |
15:00 - 15:05
Complementary imaging modalities to optimise treatment strategy?
| Speaker: | Daniel van den Heuvel, Nieuwegein |
15:05 - 15:10
Audience participation and discussion
15:10 - 15:15
Treating challenging calcified lesions in CLI: From the common femoral to the foot?
| Speaker: | Grigorios Korosoglou, Weinheim, Germany |
15:15 - 15:20
Audience participation and discussion
15:20 - 15:25
New horizons in optimised lower limb angioplasty? IVUS-guided dissection detection and management with a first-of-its-kind dissection repair device?
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |
15:25 - 15:30
Audience participation and discussion
Novel technology controversies
Time: 15:30 - 16:30 London time (BST)
| Moderators: | Thomas Zeller, Bad Krozingen, Germany |
| Gunnar Tepe, Rosenheim, Germany |
15:30 - 15:35
Amputation-free survival and limb salvage with deep venous arterialisation
| Speaker: | Peter Schneider, San Francisco, United States |
15:35 - 15:40
Audience participation and discussion
15:40 - 15:45
Edited case: Deep venous arterialisation
| Speaker: | Andrew Holden, Auckland, New Zealand |
15:45 - 15:50
Audience participation and discussion
15:50 - 15:55
The impact of socio-economic and clinical variables on the incidence of major amputation in people with diabetic foot ulcers
| Speaker: | William Jeffcoate, Nottingham, United Kingdom |
15:55 - 16:00
Audience participation and discussion
16:00 - 16:05
Results of the PRELUDE-BTK study: Novel serration angioplasty balloon for the below-the-knee arteries
| Speaker: | Andrew Holden, Auckland, New Zealand |
16:05 - 16:10
Audience participation and discussion
16:10 - 16:20
CX Debate: Paclitaxel-coated balloon should be treatment of choice for preventing restenosis in below-the-knee interventions
For the motion
16:10 - 16:15
| Francesco Liistro, Arezzo, Italy |
Against the motion
16:15 - 16:20
| Robert Hinchliffe, Bristol, United Kingdom |
16:20 - 16:30
Audience participation, discussion and polling
Networking break
Time: 16:30 - 17:00 London time (BST)
Satellite Symposium: Real data and experience for BTK bypass: Vein versus heparin-bonded ePTFE
Time: 16:30 - 17:00 London time (BST)
| Moderators: | Richard Neville, Falls Church, United States |
| Walter Dorigo, Italy |
16:30 - 16:38
Criteria analysis for use of heparin-bonded ePTFE as first choice conduit in below-knee bypass: Multicentric registry
| Speaker: | Walter Dorigo, Italy |
16:38 - 16:45
Audience participation and discussion
16:45 - 16:53
Heparin-bonded ePTFE: is it as good as autologous vein for tibial bypass?
| Speaker: | Richard Neville, Falls Church, United States |
16:53 - 17:00
Audience participation and discussion
The hurting leg controversies
Time: 17:00 - 18:00 London time (BST)
| Moderators: | Gunnar Tepe, Rosenheim, Germany |
| Robert Hinchliffe, Bristol, United Kingdom |
17:00 - 17:05
Podium 1st: Five-year outcomes of DCB treatment in critical limb ischaemia from the IN.PACT Global Study
| Speaker: | Michel Reijnen, Arnhem, Netherlands |
17:05 - 17:10
Audience participation and discussion
17:10 - 17:15
Chronic limb-threatening ischaemia: Options for treatment - open surgery vein and grafts
| Speaker: | Richard Neville, Falls Church, United States |
17:15 - 17:20
Audience participation and discussion
17:20 - 17:25
Catheter-directed thrombolysis versus aspiration thrombectomy in the management of acute limb ischaemia - lessons learned from a multicentre retrospective physician-initiated registry
| Speaker: | Maria Antonella Ruffino, Turin, Italy |
17:25 - 17:30
Audience participation and discussion
17:30 - 17:35
Prediction model for freedom from TLR from a multi-study analysis of long-term results with a drug-eluting stent
| Speaker: | Michael Dake, Tucson, United States |
17:35 - 17:40
Audience participation and discussion
17:40 - 17:45
Budget impact analysis of heparin-bonded ePTFE grafts against standard ePTFE grafts for below-the-knee bypass in patients with critical limb ischaemia
| Speaker: | Yann Goueffic, Paris, France |
17:45 - 17:50
Audience participation and discussion
17:50 - 17:55
Experience and long-term outcomes with infrapopliteal drug-eluting stents in patients with critical limb ischaemia
| Speaker: | Claudia Riera Hernandez, Barcelona, Spain |
17:55 - 18:00
Audience participation and discussion
Networking break
Time: 18:00 - 18:30 London time (BST)
Satellite Symposium: Simplifying calcium treatment with intravascular lithotripsy (IVL)
Time: 18:00 - 18:30 London time (BST)
| Moderator: | Andrew Holden, Auckland, New Zealand |
18:00 - 18:08
IVL: Cracking through the data: PADIII RCT and PADIII OS long lesion subset
| Speaker: | Andrew Holden, Auckland, New Zealand |
18:08 - 18:16
IVL: An intuitive solution to the challenge of severe calcium in CLTI patients
| Speaker: | Konstantinos Stavroulakis, Muenster, Germany |
18:16 - 18:24
IVL: Safely breaking down the access barrier of calcified iliac arteries for EVAR/TEVAR
| Speaker: | Stefano Fazzini, Rome, Italy |
18:24 - 18:30
Audience participation and discussion
Intervention considerations controversies
Time: 18:30 - 19:00 London time (BST)
| Moderators: | Thomas Zeller, Bad Krozingen, Germany |
| Andrew Holden, Auckland, New Zealand |
18:30 - 18:35
Impact of chronic kidney disease on the outcomes of infrapopliteal venous and heparin-bonded expanded polytetrafluoroethylene bypass surgeries
| Speaker: | Markus Steinbauer, President DGG, Regensburg, Germany |
18:35 - 18:40
Audience participation and discussion
18:40 - 18:45
PRESTIGE Trial: Multicentre trial analysing IVUS-guided atherectomy below-the-knee in patients with critical limb ischaemia
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |
18:45 - 18:50
Audience participation and discussion
18:50 - 18:55
Functional outcome after major limb amputation in vascular surgery
| Speaker: | Arsalan Wafi, Southall, United Kingdom |
18:55 - 19:00
Audience participation and discussion
Roundtable: Unacceptable high major amputation rate - urgent advance needed
Time: 19:00 - 19:30 London time (BST)
19:00 - 19:05
The diabetologist's perspective
| Speaker: | Michael Edmonds, London, United Kingdom |
19:05 - 19:10
The vascular surgeon's perspective
| Speaker: | Robert Hinchliffe, Bristol, United Kingdom |
19:10 - 19:15
The interventional radiologist's perspective
| Speaker: | Gunnar Tepe, Rosenheim, Germany |
19:15 - 19:30
Audience participation and discussion